Annals of Clinical Biochemistry > Annals of Clinical Biochemistry Online First > 10.1258/acb.2008.008029

This Article Full Text (PDF) All Versions of this Article: acb.2008.008029v1 45/6/575    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Carling, R S Articles by Calvin, J Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original Article

Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry

R S Carling¹, S L Hogg¹, T C Wood² and J Calvin¹

¹ Biochemical Genetics Unit, Box 247, Addenbrookes Hospital, Hills Road, Cambridge CB2 0QQ, UK; ² Biochemical Genetics Laboratory, Greenwood Genetic Center, 125 Gregor Mendel Circle, Greenwood SC 29646, USA

Corresponding author: Dr R S Carling. Email: rachel.carling{at}nhs.net

Background: Creatine plays an important role in the storage and transmission of phosphate-bound energy. The cerebral creatine deficiency syndromes (CCDS) comprise three inherited defects in creatine biosynthesis and transport. They are characterized by mental retardation, speech and language delay and epilepsy. All three disorders cause low-creatine signal on brain magnetic resonance spectroscopy (MRS); however, MRS may not be readily available and even when it is, biochemical tests are required to determine the underlying disorder.

Methods: Analysis was performed by liquid chromatography-tandem mass spectrometry in positive ionization mode. Samples were analysed underivatized using a rapid ‘dilute and shoot’ approach. Chromatographic separation of the three compounds was achieved. Stable isotope internal standards were used for quantification.

Results: Creatine, creatinine and guanidinoacetate were measured with a 2.5 minute run time. For guanidinoacetate, the standard curve was linear to at least 5000 µmol/L and for creatine and creatinine it was linear to at least 25 mmol/L. The lower limit of quantitation was 0.4 µmol/L for creatine and guanidinoacetate and 0.8 µmol/L for creatinine. Recoveries ranged from 86% to 106% for the three analytes. Intra- and inter-assay variation for each analyte was <10% in both urine and plasma.

Conclusion: A tandem mass spectrometric method has been developed and validated for the underivatized determination of guanidinoacetate, creatine and creatinine in human urine and plasma. Minimal sample preparation coupled with a rapid run time make the method applicable to the routine screening of patients with suspected CCDS.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?